cisapride has been researched along with Enterocolitis, Necrotizing in 1 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Enterocolitis, Necrotizing: ENTEROCOLITIS with extensive ulceration (ULCER) and NECROSIS. It is observed primarily in LOW BIRTH WEIGHT INFANT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cisapride is a potentially useful therapy in patients with pediatric short-bowel syndrome with gastrointestinal dysmotility." | 2.76 | Cisapride improves enteral tolerance in pediatric short-bowel syndrome with dysmotility. ( Duggan, C; Hart, K; Jaksic, T; Jiang, H; Kamin, DS; Nurko, S; Raphael, BP, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raphael, BP | 1 |
| Nurko, S | 1 |
| Jiang, H | 1 |
| Hart, K | 1 |
| Kamin, DS | 1 |
| Jaksic, T | 1 |
| Duggan, C | 1 |
1 trial available for cisapride and Enterocolitis, Necrotizing
| Article | Year |
|---|---|
Cisapride improves enteral tolerance in pediatric short-bowel syndrome with dysmotility.
Topics: Child; Child, Preschool; Cisapride; Citrulline; Energy Intake; Enteral Nutrition; Enterocolitis, Nec | 2011 |